New Delhi: Bharat Biotech’s COVID-19 vaccine ‘Covaxin’ has received approval for Emergency use in children between 12 to 18 years of age. In a statement, Bharat Biotech said, Covaxin is …
Bharat Biotech’s Covaxin gets nod for emergency use in children Read More
New Delhi, The Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) met on 1st and 2nd January, 2021 and made recommendations in respect of proposal for Restricted Emergency …
Drugs Controller General of India approves emergency use of covid19 vaccine Read More
Hyderabad: Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion …
Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech Read More
Hyderabad, Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the …
Animal study proved Covid vaccine’s efficacy: Bharat Biotech Read More Hyderabad: Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India’s first indigenous Covid-19 vaccine Covaxin began across the country on July 15. “This is a randomised, double-blind, …
Clinical trials begin for Bharat Biotech’s Covid-19 vaccine Read More
Chandigarh: Haryana Health Minister Anil Vij on Friday said that human trial of a vaccine against novel coronavirus has begun at the Post Graduate Institute of Medical Sciences in Rohtak. …
Bharat Biotech starts corona vaccine trial at PGI-Rohtak: Vij Read More
New Delhi: The Indian Council of Medical Research (ICMR) on Saturday partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for coronavirus. According to a statement issued …
ICMR partners with Bharat Biotech to develop Covid-19 vaccine Read More
Hyderabad: Vaccine maker Bharat Biotech is developing a unique intranasal vaccine for Coronavirus. An international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies FluGen along with Bharat …
Bharat Biotech to develop intranasal coronavirus vaccine Read More